Standard BioTools

Standard BioTools is a mission-driven company focused on unleashing tools to accelerate breakthroughs in human health through its high-parameter, high-throughput omics platforms. The company has established itself as a leader in single-cell and spatial proteomics, overcoming the limitations of traditional fluorescence-based methods, while also maintaining a strong position in microfluidics-based genomics. Its strategy centers on empowering translational researchers with integrated, standardized workflows to generate deep, actionable biological insights from discovery through to clinical research.

A portfolio of precision omics platforms including mass cytometry for single-cell proteomics (CyTOF), imaging mass cytometry for spatial proteomics (Hyperion), and high-throughput microfluidics for genomics (Biomark), all designed for best-in-class consistency and reproducibility.

Competes in single-cell/spatial proteomics against fluorescence/spectral flow cytometry (BD, Beckman) and multiplexed imaging (Akoya, Lunaphore). In genomics, competes with high-throughput qPCR and NGS prep solutions from Thermo Fisher, Roche, and Bio-Rad. Faces broad competition for capital and customer spend from large, diversified tools companies.